Urethral Stricture and Buccal Mucosal Graft Urethroplasty: A Modern Solution to an Ancient Problem
There is an uncomfortable irony in the fact that one of the most effective surgical repairs in urology borrows tissue from the inside of a patient’s cheek. Buccal mucosal graft urethroplasty — a procedure in which the lining of the mouth is harvested and used to reconstruct a scarred, narrowed urethra — has quietly become one of the most important reconstructive advances in urological surgery over the past three decades.
Urethral stricture disease affects an estimated 300 per 100,000 men worldwide. It causes the urethra — the tube that carries urine from the bladder out of the body — to become abnormally narrowed by scar tissue, restricting or blocking urine flow. Left unmanaged, it can lead to infections, bladder damage, and kidney injury. For mild cases, simpler procedures suffice. But for longer, more complex, or recurrent strictures, urethroplasty using a buccal mucosal graft has emerged as the gold standard — offering high success rates and durable long-term outcomes that simpler approaches simply cannot match.
What Is a Urethral Stricture?
The urethra is a tubular structure lined by specialized epithelium (mucosa) and surrounded by a spongy erectile tissue called the corpus spongiosum. When the urethra is injured — by trauma, infection, prior instrumentation, or inflammation — the healing process can produce fibrous scar tissue (spongiofibrosis) that progressively narrows the urethral lumen.
Common Causes
Urethral strictures can develop from a variety of causes, and identifying the underlying etiology helps guide treatment:
- Idiopathic: No identifiable cause; the most common category in developed countries
- Iatrogenic: Caused by prior urethral instrumentation — catheterization, cystoscopy, endoscopic procedures, or prior surgery
- Traumatic: Pelvic fractures or straddle injuries (falls onto the perineum) causing direct urethral injury
- Inflammatory: Infections, particularly gonorrhea historically, or lichen sclerosus (a chronic inflammatory skin condition affecting the genital area)
- Congenital: Rare; strictures present from birth
The anterior urethra (the bulbar and penile portions) is the most commonly affected segment, and it is here that buccal mucosal graft urethroplasty has proven most valuable.
Recognizing the Symptoms
Urethral stricture symptoms often develop gradually, and many men attribute them to aging or benign prostate issues before receiving a correct diagnosis. Warning signs include:
- Weak, split, or spraying urinary stream
- Difficulty initiating urination
- A sensation of incomplete bladder emptying
- Frequent or urgent urination
- Recurrent urinary tract infections
- Dribbling after urination ends
- In severe cases, complete urinary retention — a urological emergency
Diagnosis is confirmed through a combination of uroflowmetry (measuring urine flow rate), retrograde urethrography (an X-ray using contrast dye to map stricture location and length), and cystoscopy (direct visual examination of the urethra).
Why Simple Treatments Often Fail
The most commonly performed first-line treatment for urethral stricture is direct visual internal urethrotomy (DVIU) — an endoscopic procedure in which the scar tissue is cut from the inside, under direct vision. It is quick, minimally invasive, and requires no incision. But therein lies its limitation: it treats the surface of the stricture without removing or replacing the underlying scarred tissue. Recurrence rates after a single urethrotomy exceed 50% within two years for strictures longer than 1.5 cm, and repeat procedures have progressively lower success rates.
Urethral dilation — stretching the stricture mechanically — has an even higher recurrence rate and is now considered an interim measure rather than a definitive treatment for most strictures.
For patients with longer strictures, multiple recurrences, or strictures in segments where simple incision is ineffective, urethroplasty — open surgical reconstruction of the urethra — remains the only durable solution.
What Is Buccal Mucosal Graft Urethroplasty?
Urethroplasty involves surgically opening the scarred segment of the urethra and either removing the stricture entirely (excision and primary anastomosis) or widening it using a tissue graft. For strictures longer than approximately 2 cm or located in segments where excision would risk penile curvature or shortening, augmentation using a graft is the preferred approach.
The buccal mucosal graft (BMG) — harvested from the inner lining of the cheek or, alternatively, the lower lip — has become the tissue substitute of choice for urethral reconstruction. The technique was refined and popularized through publications from multiple centers, including the influential contributions of reconstructive urologists at institutions like King George’s Medical University (KGMU) in Lucknow, India, where Vishwajeet Singh and colleagues published extensively on their BMG urethroplasty experience.
Why Buccal Mucosa?
Buccal mucosa has several properties that make it biologically ideal for urethral reconstruction:
- Thick epithelium with a thin lamina propria: Easy to harvest, handle, and suture
- Highly vascularized submucosal layer: Promotes rapid graft take and integration
- Naturally moist environment: Adapted to function in wet conditions similar to the urethra
- Abundant availability: The inner cheek offers sufficient graft length (up to 12–14 cm) for most strictures
- Low donor site morbidity: The mouth heals quickly; serious complications at the harvest site are uncommon
- Resistance to infection: Oral mucosa has inherent antimicrobial properties
Surgical Technique: How the Procedure Works
BMG urethroplasty is performed under general or spinal anesthesia. It typically proceeds in two coordinated steps: graft harvest and urethral reconstruction.
Step 1: Harvesting the Buccal Mucosal Graft
The inner cheek mucosa is infiltrated with local anesthetic containing epinephrine to reduce bleeding and facilitate harvest. An appropriately sized ellipse of mucosa is excised, defatted, and prepared on a backing board. The donor site is either closed with absorbable sutures or left to heal by secondary intention — both approaches produce reliable healing in most patients.
Step 2: Urethral Reconstruction
The strictured segment of the urethra is exposed through a perineal incision. The stricture is opened longitudinally (a technique called “urethrotomy”), and the buccal graft is sutured into the defect to widen the urethral lumen. The graft can be placed on the dorsal surface (the roof of the urethra, resting against the corporal bodies — the Barbagli technique) or on the ventral surface (the floor of the urethra). Dorsal onlay placement has become preferred for bulbar urethral strictures due to superior graft support and lower complication rates.
A urethral catheter is left in place postoperatively for 3–4 weeks while the graft integrates and heals.
Outcomes: What the Evidence Shows
| Outcome Measure | DVIU (Single Procedure) | Repeat DVIU | BMG Urethroplasty |
| Short-term success rate | 50–80% | 30–50% | 85–95% |
| Long-term success (>5 yrs) | 20–30% | <20% | 80–90% |
| Suitable for long strictures (>2 cm) | No | No | Yes |
| Risk of recurrence | High | Very high | Low–moderate |
| Donor site needed | No | No | Yes (oral mucosa) |
| Anesthesia required | Spinal/general | Spinal/general | General/spinal |
| Recovery time | Days | Days | 4–6 weeks |
Data pooled from multiple systematic reviews and institutional series, including published outcomes from Indian centers with high-volume BMG urethroplasty experience.
Success rates consistently exceed 85% at one year and remain above 80% at five-year follow-up in experienced centers. Success is typically defined as the absence of stricture recurrence, confirmed by uroflowmetry and imaging, with the patient voiding freely without catheterization or further intervention.
Donor Site Considerations and the Role of Tobacco
One underappreciated aspect of BMG urethroplasty is that the donor site — the mouth — is not entirely without consequences. Research from KGMU, published in BMC Urology (Sinha, Singh et al., 2009), specifically examined donor site morbidity in patients who underwent oral mucosa graft urethroplasty and found that tobacco use — whether through smoking, chewing, or paan masala consumption — was associated with significantly worse healing outcomes at the harvest site.
Tobacco users experienced greater pain, swelling, and prolonged discomfort compared to non-users, and poor oral hygiene compounded these effects. This finding has practical implications: patients scheduled for BMG urethroplasty should be counseled to quit or reduce tobacco use before surgery, maintain meticulous oral hygiene, and be advised of the expected donor site recovery course.
Other possible donor site effects include:
- Temporary numbness of the inner cheek
- Tightness or restricted mouth opening (trismus) — usually temporary
- Minor bleeding from suture lines
- Rarely, changes in salivary gland function
Serious or permanent complications at the donor site are uncommon when the procedure is performed by an experienced surgeon using careful technique.
Who Is a Good Candidate?
BMG urethroplasty is generally recommended for:
- Strictures longer than 1.5–2 cm that are unlikely to respond durably to urethrotomy
- Recurrent strictures following one or more failed urethrotomies or dilations
- Lichen sclerosus-associated strictures involving the penile urethra or meatus
- Pan-urethral strictures affecting multiple segments
- Patients who have failed prior urethroplasty using other graft materials
It may not be the first choice for very short, isolated bulbar strictures (where excision and end-to-end anastomosis produces excellent results) or in patients with significant oral pathology that makes graft harvest unsafe.
Conclusion: A Well-Established Gold Standard
Buccal mucosal graft urethroplasty represents one of the genuine success stories of reconstructive urology. What began as an innovative adaptation of oral surgery principles has evolved into a well-validated, widely practiced technique with a robust evidence base spanning more than two decades of published outcomes data. For men with complex, long, or recurrent urethral strictures, it offers something that simpler procedures cannot: a durable, tissue-based reconstruction with high long-term success rates and an acceptable risk profile.
If you are experiencing symptoms of urethral stricture — particularly weak urine flow, recurrent infections, or difficulty voiding — early consultation with a urologist is essential. A timely diagnosis allows treatment to be tailored to stricture characteristics before disease progression limits options. The evidence strongly supports that for appropriate candidates, urethroplasty — rather than repeated endoscopic procedures — should be the definitive treatment of choice.
For peer-reviewed research on urethral stricture management and reconstructive urology, visit Urology Journal.